Kelly CRISPR & Gene Editing Technology ETF (XDNA) Short Interest Ratio & Short Volume → How this is some devastating news (From WealthPress) (Ad) Free XDNA Stock Alerts $7.38 -0.12 (-1.60%) (As of 11/30/2023) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesHoldingsOptions ChainRatingsSocial MediaStock AnalysisChartHeadlinesHoldingsOptions ChainRatingsSocial Media Kelly CRISPR & Gene Editing Technology ETF Short Interest DataCurrent Short Volume7,100 sharesPrevious Short Volume18,500 sharesChange Vs. Previous Month-61.62%Dollar Volume Sold Short$48,777.00Short Interest Ratio / Days to Cover1.8Last Record DateNovember 15, 2023Outstanding Shares300,000 sharesPercentage of Shares Shorted2.37%Today's Trading Volume4,200 sharesAverage Trading Volume3,034 sharesToday's Volume Vs. Average138% Short Selling Kelly CRISPR & Gene Editing Technology ETF ? Sign up to receive the latest short interest report for Kelly CRISPR & Gene Editing Technology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXDNA Short Interest Over TimeXDNA Days to Cover Over TimeXDNA Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Kelly CRISPR & Gene Editing Technology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20237,100 shares $48,777.00 -61.6%N/A1.8 $6.87 10/31/202318,500 shares $117,845.00 +112.6%N/A5.3 $6.37 10/15/20238,700 shares $60,987.00 -5.4%N/A3.1 $7.01 9/30/20239,200 shares $68,264.00 -8.9%N/A3.1 $7.42 9/15/202310,100 shares $81,911.00 +13.5%N/A3.3 $8.11 8/31/20238,900 shares $73,870.00 -24.6%N/A2.9 $8.30 8/15/202311,800 shares $101,834.00 -28.1%N/A3.8 $8.63 7/31/202316,400 shares $153,832.00 +485.7%N/A6.3 $9.38 7/15/20232,800 shares $26,096.00 -6.7%N/A1.1 $9.32 6/30/20233,000 shares $26,730.00 -9.1%N/A1.2 $8.91 6/15/20233,300 shares $31,251.00 +135.7%N/A1.3 $9.47 5/31/20231,400 shares $12,726.00 +7.7%N/A0.5 $9.09 5/15/20231,300 shares $12,829.31 No ChangeN/A0.5 $9.87 XDNA Short Interest - Frequently Asked Questions What is Kelly CRISPR & Gene Editing Technology ETF's current short interest? Short interest is the volume of Kelly CRISPR & Gene Editing Technology ETF shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 7,100 shares of XDNA short. Learn More on Kelly CRISPR & Gene Editing Technology ETF's current short interest. What is a good short interest ratio for Kelly CRISPR & Gene Editing Technology ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XDNA shares currently have a short interest ratio of 2.0. Learn More on Kelly CRISPR & Gene Editing Technology ETF's short interest ratio. Is Kelly CRISPR & Gene Editing Technology ETF's short interest increasing or decreasing? Kelly CRISPR & Gene Editing Technology ETF saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 7,100 shares, a decrease of 61.6% from the previous total of 18,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kelly CRISPR & Gene Editing Technology ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Kelly CRISPR & Gene Editing Technology ETF: Global X Wind Energy ETF (119.10%), SPDR MSCI USA Climate Paris Aligned ETF (0.13%), Global X PropTech ETF (300.20%), VanEck Green Infrastructure ETF (73.50%), ProShares Ultra Nasdaq Cybersecurity ETF (3.22%), First Trust Indxx Metaverse ETF (2.60%), iShares Breakthrough Environmental Solutions ETF (2.63%), Xtrackers US Green Infrastructure Select Equity ETF (0.59%), Pacer BlueStar Engineering the Future ETF (1.25%), Pacer BlueStar Digital Entertainment ETF (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Kelly CRISPR & Gene Editing Technology ETF stock? Short selling XDNA is an investing strategy that aims to generate trading profit from Kelly CRISPR & Gene Editing Technology ETF as its price is falling. XDNA shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kelly CRISPR & Gene Editing Technology ETF? A short squeeze for Kelly CRISPR & Gene Editing Technology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XDNA, which in turn drives the price of the stock up even further. How often is Kelly CRISPR & Gene Editing Technology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XDNA, twice per month. The most recent reporting period available is November, 15 2023. More Short Interest Resources from MarketBeat Related Companies: WNDY Short Interest Data NZUS Short Interest Data PTEC Short Interest Data RNEW Short Interest Data UCYB Short Interest Data ARVR Short Interest Data ETEC Short Interest Data UPGR Short Interest Data BULD Short Interest Data ODDS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XDNA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits